October 26 - 31, 2014
Omni Parker House Hotel
Boston, Massachusetts, USA
An Innovative Workshop for Basic Scientists Pursuing Training in Order to Transition into Translational Cancer Research
Oct. 26-31, 2014Omni Parker House HotelBoston, Mass.
Applications are no longer being
accepted for the 2014 Translational Cancer Research for Basic Scientists
Workshop. The application deadline was Monday, May 12.
Workshop Co-DirectorsTom Curran, The Children's Hospital of Philadelphia, Philadelphia, Pa.George D. Demetri, Dana-Farber Cancer Institute, Boston, Mass.Pasi A. Jänne, Dana-Farber Cancer Institute, Boston, Mass.
Program CommitteePeter C. Adamson, The Children's Hospital of Philadelphia, Philadelphia, Pa.Suzanne J. Baker, St. Jude’s Research Hospital, Memphis, Tenn.Edward J. Benz, Dana-Farber Cancer Institute, Boston, Mass.Keith T. Flaherty, Massachusetts General Hospital Cancer Center, Boston, Mass.Jennifer R. Grandis, University of Pittsburgh, Pittsburgh, Pa.Susan Band Horwitz, Albert Einstein College of Medicine, Bronx, N.Y.Richard M. Marais, Cancer Research UK Manchester Institute, Manchester, U.K.Olufunmilayo I. Olopade, University of Chicago, Chicago, Ill.Mark E. Robson, Memorial Sloan Kettering Cancer Center, New York, N.Y.
An intensive, week-long introduction to translational cancer research – including cancer medicine, the clinical cancer research environment and collaborative team science – for basic scientists who are predoctoral students and postdoctoral fellows, early-career scientists and senior scientists in transition to translational research. This workshop is hosted in close collaboration with the Dana-Farber Cancer Institute/Harvard Cancer Center, comprised of Beth Israel Deaconess Medical Center, Brigham and Women’s Hospital, Children’s Hospital Boston, Dana-Farber Cancer Institute, Harvard Medical School, Harvard School of Public Health and Massachusetts General Hospital.
The Translational Cancer Research for Basic Scientists Workshop will provide basic research scientists with a better understanding of translational research, teach them how to adapt their research for maximum clinical impact and help them transition into a new career in translational cancer medicine. This innovative workshop addresses many aspects of translational research including leading multidisciplinary teams, working collaboratively and effectively with industry partners, recognizing the unique needs and environment of the clinic and clinical laboratories, dealing with the regulatory and compliance issues in translational science, and understanding the perspective of the patient in order to place research questions into a broader context. During the course of the week, attendees will gain perspective and background knowledge of the disease from translational scientists in academia and industry, clinicians and patients, while learning about the latest methods and approaches in cutting-edge translational cancer research.
This innovative workshop, held in 2010, 2011, and 2012, received overwhelmingly positive feedback. Previous workshops consisted of more than 25 faculty members providing core didactic lectures, nearly 15 additional health care professionals participating as lab/discussion leaders and more than 35 clinicians supervising off-site visits. We are excited to offer this outstanding educational program again, to promote the professional development of early-career investigators in translational cancer research.
Comments from previous attendees:
For further information, please contact Lyngine Calizo, Ph.D., Program Administrator, at 215-446-7265 or firstname.lastname@example.org.